NCT00256321View on ClinicalTrials.gov

Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Gastric CarcinomaGastroesophageal Junction Carcinoma
Interventions
DRUG

Oxaliplatin

Oxaliplatin 70mg/m2 IV on Days 1 and 8

DRUG

Capecitabine

Capecitabine 1000mg/m2 PO BID from Days 1 through 14.

DRUG

Celecoxib

Celecoxib 400mg PO BID from Days 1 through 21.

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, Orange

Sponsors

Collaborators (1)

Sanofi-Synthelabo
All Listed Sponsors
collaborator

Sanofi-Synthelabo

INDUSTRY

lead

University of California, Irvine

OTHER